Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Recent Advances in Nanoparticles for Gene Delivery"
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Gene and Cell Therapy".
Deadline for manuscript submissions: 30 September 2023 | Viewed by 1127
Special Issue Editors
Interests: nanomedicine; gene/drug delivery; anticancer; gene therapy; nanoparticles; gene expression; gene silencing
Interests: nanoparticles; advanced materials; polymer-metal composites; biopolymers; drug delivery; anticancer
Special Issue Information
Gene therapy has been popular as a strategy to address the shortcomings of many conventional treatments of various diseases. To realise the potential of gene therapy, the delivery of therapeutic genes must be accomplished in a safe and efficient manner. Although viral vectors have been favoured, their safety concerns have been a challenge. Hence, the use of non-viral vehicles such as nanoparticles has generated interest. Nanoparticles have since their inception shown potential for gene delivery, which is still not fully exploited.
This Special Issue aims to collate recent progress in the area of gene delivery using nanoparticles that can promote efficient binding and delivery of specific genes to treatment diseases. We invite articles on the synthesis, characterization, and modification of nanoparticles (lipid-based, organic, inorganic, or carbon-based nanoparticles) that show potential as ideal gene delivery vehicles. Advances in nanoparticles containing specific targeting ligands or display stimuli-responsive behaviour are of particular interest.
In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:
- Gene delivery
- Targeting ligands
- Nanoparticle functionalization
- Nanoparticle characterization
We look forward to receiving your contributions.
Prof. Dr. Mogie Singh
Dr. Kaushik Pal
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- gene delivery
- targeting ligands
- nanoparticle functionalization
- nanoparticle characterization